Cellular senescence-like features of lung fibroblasts derived from idiopathic pulmonary fibrosis patients

Aging

Volumn 7, Issue 9, 2015, Pages 664-672

  Yanai, Hagai ^a   Shteinberg, Albert ^a   Porat, Ziv ^b   Budovsky, Arie ^a,c   Braiman, Alex ^a   Zeische, Rolf ^d   Fraifeld, Vadim E ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c Judea Regional Research and Development Center   (Israel)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aging; Cellular senescence; Fibroblasts; Idiopathic pulmonary fibrosis; Myofibroblasts

Indexed keywords

ACTA2 PROTEIN, HUMAN; ACTIN; BETA GALACTOSIDASE;

AGED; BIOSYNTHESIS; CELL AGING; CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE COURSE; FIBROBLAST; GENETICS; HUMAN; LUNG; LUNG FIBROSIS; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY;

ACTINS; AGED; BETA-GALACTOSIDASE; CELL AGING; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DISEASE PROGRESSION; FIBROBLASTS; HUMANS; LUNG; MIDDLE AGED; OXIDATIVE STRESS; PULMONARY FIBROSIS;

EID: 84943413120     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100807     Document Type: Article

References (42)

1. MetchnikoffE. The nature of man: studies in optimistic philosophy, G.P. Putnam's Sons Publishing. (1905).
2. Ziesche R, Golec M, Samaha E. The RESOLVE concept: Approaching pathophysiology of fibroproliferative disease in aged individuals. Biogerontology. 2013; 14:679-685.
3. Thannickal VJ. Aging, antagonistic pleiotropy and fibrotic disease. Int J Biochem Cell Biol. 2010; 42:1398-1400.
4. Boorsma CE, Dekkers BG, van Dijk EM, Kumawat K, Richardson J, Burgess JK, John AE. Beyond TGFbeta--novel ways to target airway and parenchymal fibrosis. Pulm Pharmacol Ther. 2014; 29:166-180.
5. Leung J, Cho Y, Lockey RF, Kolliputi N. The role of aging in idiopathic pulmonary fibrosis. Lung. 2015.
6. Visscher DW, Myers JL. Histologic spectrum of idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006; 3:322-329.
7. Raghu G. Idiopathic pulmonary fibrosis: Guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011. Eur Respir J. 2011; 37:743-746.
8. Hecker L, Logsdon NJ, Kurundkar D, Kurundkar A, Bernard K, Hock T, Meldrum E, Sanders YY, Thannickal VJ. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med. 2014; 6:231ra47.
9. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006; 174:810-816.
10. Thannickal VJ, Loyd JE. Idiopathic pulmonary fibrosis: A disorder of lung regeneration? Am J Respir Crit Care Med. 2008; 178:663-665.
11. Borensztajn K, Crestani B, Kolb M. Idiopathic pulmonary fibrosis: From epithelial injury to biomarkers--insights from the bench side. Respiration. 2013; 86:441-452.
12. Jenkins G, Goodwin A. Novel approaches to pulmonary fibrosis. Clin Med. 2014; 14 Suppl 6:s45-9.
13. Nho RS, Im J, Ho YY, Hergert P. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix. Am J Physiol Lung Cell Mol Physiol. 2014; 307:L632-42.
14. Nho RS, Hergert P. IPF fibroblasts are desensitized to type I collagen matrix-induced cell death by suppressing low autophagy via aberrant Akt/mTOR kinases. PLoS One. 2014; 9:e94616.
15. Li Y, Jiang D, Liang J, Meltzer EB, Gray A, Miura R, Wogensen L, Yamaguchi Y, Noble PW. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J Exp Med. 2011; 208:1459-1471.
16. Prasad S, Hogaboam CM, Jarai G. Deficient repair response of IPF fibroblasts in a co-culture model of epithelial injury and repair. Fibrogenesis Tissue Repair. 2014; 7:7-1536-7-7. eCollection 2014.
17. Huang WT, Akhter H, Jiang C, MacEwen M, Ding Q, Antony V, Thannickal VJ, Liu RM. Plasminogen activator inhibitor 1, fibroblast apoptosis resistance, and aging-related susceptibility to lung fibrosis. Exp Gerontol. 2015; 61:62-75.
18. Ramos C, Montano M, Garcia-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol. 2001; 24:591-598.
19. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013; 153:1194-1217.
20. Chilosi M, Carloni A, Rossi A, Poletti V. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Transl Res. 2013; 162:156-173.
21. Zuba-Surma EK, Kucia M, Abdel-Latif A, Lillard JW, Jr, Ratajczak MZ. The ImageStream system: A key step to a new era in imaging. Folia Histochem Cytobiol. 2007; 45:279-290
22. Yanai H, Budovsky A, Tacutu R, Fraifeld VE. Is rate of skin wound healing associated with aging or longevity phenotype? Biogerontology. 2011; 12:591-597.
23. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011; 208:1339-1350.
24. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008; 453:314-321.
25. Lekkerkerker AN, Aarbiou J, van Es T, Janssen RA. Cellular players in lung fibrosis. Curr Pharm Des. 2012; 18:4093-4102.
26. Tacutu R, Budovsky A, Yanai H, Fraifeld VE. Molecular links between cellular senescence, longevity and age-related diseases - a systems biology perspective. Aging (Albany NY). 2011; 3:1178-1191.
27. Blagosklonny MV. Cell senescence: Hypertrophic arrest beyond the restriction point. J Cell Physiol. 2006; 209:592-597.
28. Ovadya Y, Krizhanovsky V. Senescent cells: SASPected drivers of age-related pathologies. Biogerontology. 2014; 15:627-642.
29. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961; 25:585-621.
30. Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev. 2008; 129:467-474.
31. Alder JK, Chen JJ, Lancaster L, DanoffS, Su SC, Cogan JD, Vulto I, Xie M, Qi X, Tuder RM, Phillips JA,3rd, Lansdorp PM, Loyd JE et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A. 2008; 105:13051-13056.
32. Alder JK, Barkauskas CE, Limjunyawong N, Stanley SE, Kembou F, Tuder RM, Hogan BL, Mitzner W, Armanios M. Telomere dysfunction causes alveolar stem cell failure. Proc Natl Acad Sci U S A. 2015; 112:5099-5104.
33. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips JA,3rd, Lansdorp PM, Greider CW, Loyd JE. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med. 2007; 356:1317-1326.
34. Armanios M. Telomerase and idiopathic pulmonary fibrosis. Mutat Res. 2012; 730:52-58.
35. Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, Rosenblatt RL, Garcia CK. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med. 2008; 178:729-737.
36. Dai J, Cai H, Zhuang Y, Wu Y, Min H, Li J, Shi Y, Gao Q, Yi L. Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a chinese population. Respirology. 2015; 20:122-128.
37. Thannickal VJ. Mechanistic links between aging and lung fibrosis. Biogerontology. 2013; 14:609-615.
38. Carloni A, Poletti V, Fermo L, Bellomo N, Chilosi M. Heterogeneous distribution of mechanical stress in human lung: A mathematical approach to evaluate abnormal remodeling in IPF. J Theor Biol. 2013; 332:136-140.
39. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667.
40. Sarrazy V, Billet F, Micallef L, Coulomb B, Desmouliere A. Mechanisms of pathological scarring: Role of myofibroblasts and current developments. Wound Repair Regen. 2011; 19 Suppl 1:s10-5.
41. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685.
42. Adkins JM, Collard HR. Idiopathic pulmonary fibrosis. Semin Respir Crit Care Med. 2012; 33:433-439.